Fund shareholders of CorMedix Inc
ISIN US21900C3088 · United States · LEI 5299006YIA3L0MBW8358
- Fund shareholders
- 137
- Of which ETFs
- 36 101 other funds
- Value held
- ≈ 98.9M $ 98.6M $ · 247.5K €
- Share of capital
- 18.2 % of 77.9M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 4,692 | 31.9K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 4,603 | 32.8K $ | 0.01 % | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 4,591 | 32.7K $ | 0.01 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 4,414 | 31.5K $ | 0.04 % | 0.01 % | as of Feb 28, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 4,169 | 31.6K $ | 0.94 % | 0.01 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 3,638 | 25.9K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 3,215 | 22.9K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 3,037 | 23.1K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 2,788 | 19.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 2,595 | 17.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Franklin U.S. Small Cap Multifactor Index ETF Franklin Templeton ETF Trust | 2,420 | 16.4K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Lazard Enhanced Opportunities Portfolio LAZARD FUNDS INC | 2,368 | 16.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,791 | 12.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,764 | 12K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,708 | 11.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,700 | 11.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 1,679 | 11.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 1,460 | 9.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,457 | 11.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| American Century Small Cap Growth Insights ETF American Century ETF Trust | 1,246 | 8.9K $ | 0.10 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,185 | 8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 889 | 6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 838 | 6.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 581 | 3.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 389 | 3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 328 | 2.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 287 | 1.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 248 | 1.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 188 | 1.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 151 | 1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 135 | 1K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 112 | 760.5 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 90 | 611.1 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 76 | 541.9 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 22 | 156.9 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 17 | 115.4 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| KAIZEN GLOBAL INCOME, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 247.5K € | 1.28 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AUER GROWTH Unified Series Trust | 1.77 % | as of Feb 28, 2026 ↗ |
| KAIZEN GLOBAL INCOME, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 1.28 % | as of Dec 31, 2025 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.22 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.17 % | as of Mar 31, 2026 ↗ |
| Royce Capital Fund - Small-Cap Portfolio ROYCE CAPITAL FUND | 1.13 % | as of Mar 31, 2026 ↗ |
| Royce Small-Cap Value Fund ROYCE FUND | 1.13 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 0.95 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 0.94 % | as of Apr 30, 2026 ↗ |
| VictoryShares Small Cap Free Cash Flow ETF Victory Portfolios II | 0.68 % | as of Mar 31, 2026 ↗ |
| Simplify Piper Sandler US Small-Cap PLUS Income ETF Simplify Exchange Traded Funds | 0.65 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 136 | -3 | 14,166,892 | +18.0 % |
| 2026Q1 | 139 | 0 | 12,001,310 | +4.6 % |
| 2025Q4 | 139 | +13 | 11,470,466 | -2.6 % |
| 2025Q3 | 126 | +9 | 11,774,494 | +21.5 % |
| 2025Q2 | 117 | +7 | 9,688,821 | -6.3 % |
| 2025Q1 | 110 | +17 | 10,345,397 | +41.8 % |
| 2024Q4 | 93 | -1 | 7,293,572 | +5.3 % |
| 2024Q3 | 94 | +3 | 6,924,735 | -0.3 % |
| 2024Q2 | 91 | +2 | 6,945,927 | +0.1 % |
| 2024Q1 | 89 | 0 | 6,940,657 | +11.9 % |
| 2023Q4 | 89 | 6,200,923 |
Institutional managers
179 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Deep Track Capital, LP | 6,274,076 | 42.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,967,575 | 40.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,191,843 | 14.9M $ | as of Mar 31, 2026 |
| ROYCE & ASSOCIATES LP | 1,887,532 | 12.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,816,907 | 12.3M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,538,245 | 10.4M $ | as of Mar 31, 2026 |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,211,115 | 8.2M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 850,000 | 5.8M $ | as of Mar 31, 2026 |
| KENNEDY CAPITAL MANAGEMENT LLC | 673,302 | 4.6M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 637,683 | 4.3M $ | as of Mar 31, 2026 |
| Palisades Investment Partners, LLC | 610,148 | 4.1M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 602,966 | 4.1M $ | as of Mar 31, 2026 |
| Trexquant Investment LP | 560,637 | 3.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 511,329 | 3.5M $ | as of Mar 31, 2026 |
| Private Advisor Group, LLC | 504,668 | 3.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 502,965 | 3.4M $ | as of Mar 31, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | 499,803 | 3.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 435,639 | 3M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 366,513 | 2.5M $ | as of Mar 31, 2026 |
| Sculptor Capital LP | 335,900 | 2.3M $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 328,224 | 2.2M $ | as of Mar 31, 2026 |
| NEW YORK STATE COMMON RETIREMENT FUND | 297,463 | 2M $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 292,445 | 2K $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 285,070 | 1.9M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 277,784 | 1.9M $ | as of Mar 31, 2026 |
Declared shareholders of CorMedix Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Deep Track Capital, LP and 2 others | 7.94 % | 6,274,076 | as of Mar 31, 2026 · SCHEDULE 13G |
| SHAIBATALHAMD AYMEN ABDALKADER | 5.90 % | 4,618,511 | as of Jun 11, 2026 · SCHEDULE 13G |
Funds holding the debt of CorMedix Inc
3 funds declare 3 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| PACE Alternative Strategies Investments | 1 | 223.9K $ | as of Apr 30, 2026 |
| Franklin Alternative Strategies Fund | 1 | 214.1K $ | as of Feb 27, 2026 |
| BNY Mellon Core Plus Fund | 1 | 99.2K $ | as of Apr 30, 2026 |
Cite this page
Titelia. "Fund shareholders of CorMedix Inc". https://titelia.com/en/stocks/cormedix-inc-US21900C3088